Read More Pharma Industry News BeiGene gets Brukinsa FDA approval for chronic lymphocytic leukemia BeiGene has secured the approval of the US Food and Drug Administration (FDA) for the company’s Brukinsa (zanubrutinib)… byRaghuram KadariJanuary 21, 2023